Similar Articles
91 Atezolizumab and bevacizumab combination in advanced hepatocellular carcinoma patients: The imperative for safety assessment studies
92 Therapeutic potential of kakkatin derivatives against hepatocellular carcinoma
93 Transmembrane channel-like 5 drives hepatocellular carcinoma progression by regulating epithelial-mesenchymal transition
94 Radiomics and clinicoradiological factors as a promising approach for predicting microvascular invasion in hepatitis B-related hepatocellular carcinoma
95 Apatinib regulates the glycolysis of vascular endothelial cells through PI3K/AKT/PFKFB3 pathway in hepatocellular carcinoma
96 Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions
97 Physiology and health assessment, risk balance, and model for end-stage liver disease scores: Postoperative outcome of liver transplantation
98 Hepatocellular carcinoma recurrence after liver transplant: An Australian single-centre study
99 Combination therapy strategy based on selective internal radiation therapy as conversion therapy for inoperable giant hepatocellular carcinoma: A case report
100 To investigate the effect and mechanism of tetrahydrocurcumin on hepatocellular carcinoma based on phosphoinositide 3-kinases/AKT signaling pathway
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA